News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harvard Apparatus Regenerative Technology, Inc. Reports Operating Results For First Quarter Ended March 31, 2014


5/8/2014 9:12:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Harvard Apparatus Regenerative Technology, Inc. (Nasdaq:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, today reported unaudited financial results for the three months ended March 31, 2014, the Company’s first quarter of 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES